1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Invasive Meningococcal Disease: Executive Summary
2.1 Catalyst
2.2 Related Reports
2.3 Upcoming Reports

3 Epidemiology
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.3 Global and Historical Trends
3.4 Forecast Methodology
3.4.1 Sources
3.4.2 Forecast Assumptions and Methods
3.5 Epidemiological Forecast for Invasive Meningococcal Disease (2019-2029)
3.5.1 Laboratory-Confirmed Incident Cases of IMD
3.5.2 Laboratory-Confirmed Incident Cases of IMD by Serogroup, 2019 and 2029
3.5.3 Age-Specific Laboratory-Confirmed Incident Cases of IMD
3.6 Discussion
3.6.1 Epidemiological Forecast Insight
3.6.2 Limitations of Analysis
3.6.3 Strengths of Analysis

4 Appendix
4.1 Bibliography
4.2 About the Authors
4.2.1 Epidemiologist
4.2.2 Reviewers
4.2.3 Global Director of Therapy Analysis and Epidemiology
4.2.4 Global Head and EVP of Healthcare Operations and Strategy
4.3 About GlobalData
4.4 Contact Us
4.5 Disclaimer

List of Tables
Table 1: Summary of Newly Added Data Types and Countries
Table 2: Summary of Updated Data Types
Table 3: Risk Factors and Comorbidities for Invasive Meningococcal Disease

List of Figures
Figure 1: 9MM, Laboratory-Confirmed Incident Cases of IMD, Men and Women, All Ages, 2019 and 2029, N
Figure 2: 9MM, Laboratory-Confirmed Incidence Rate of IMD, Cases per 100,000 Population, Men and Women, All Ages, 2009-2019
Figure 3: 9MM, Sources Used for the Laboratory-Confirmed Incident Cases of IMD
Figure 4: 9MM, Laboratory-Confirmed Incident Cases of IMD, Men and Women, All Ages, 2019, N
Figure 5: 9MM, Laboratory-Confirmed Incident Cases of IMD by Serogroup, Men and Women, All Ages, 2019, N
Figure 6: 9MM, Laboratory-Confirmed Incident Cases of IMD by Serogroup, Men and Women, All Ages, 2029, N
Figure 7: 9MM, Laboratory-Confirmed Incident Cases of IMD by Age, Men and Women, 2019